Estimated savings in medical costs when new oral anticoagulants are used for the treatment of patients with nonvalvular atrial fibrillation and venous thromboembolism vs. Warfarin in the u.s
May 1, 2015, 00:00
10.1016/j.jval.2015.03.802
https://www.valueinhealthjournal.com/article/S1098-3015(15)00859-1/fulltext
Title :
Estimated savings in medical costs when new oral anticoagulants are used for the treatment of patients with nonvalvular atrial fibrillation and venous thromboembolism vs. Warfarin in the u.s
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00859-1&doi=10.1016/j.jval.2015.03.802
First page :
A138
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
239